![](https://emeatribune.com/wp-content/uploads/2024/06/stocks-making-the-biggest-moves-premarket-walgreens-levi-strauss-micron-and-more-980x654.jpg)
![](https://emeatribune.com/wp-content/uploads/2024/06/stocks-making-the-biggest-moves-premarket-walgreens-levi-strauss-micron-and-more-980x654.jpg)
![](https://image.cnbcfm.com/api/v1/image/107389744-17108853292021-11-26t230344z_488976910_rc2k2r9e2jtg_rtrmadp_0_walgreens-boots-results.jpeg?v=1710885476&w=1920&h=1080)
Check out the companies making headlines before the bell. Micron — Shares slipped nearly 6% after the semiconductor manufacturer posted revenue guidance of $7.6 billion for its current quarter, coming in line with analyst expectations. Micron also reported a third-quarter earnings and revenue beat. GSK — Shares of the biopharmaceutical company slid nearly 2% after the U.S. Centers for Disease Control and Prevention held off on recommending RSV vaccines for adults younger than 60. Levi Strauss — The denim maker’s stock tumbled 15.4% after revenue came in at $1.44 billion for the second fiscal quarter, slightly under the consensus forecast of $1.45 billion from analysts polled by LSEG. International Paper — The paper manufacturing company dropped 13% after Suzano decided to terminate negotiations for a potential acquisition of International Paper. Suzano said it had reached the maximum price for the transaction to general value without having heard from the other party. Walgreens Boots Alliance — Shares tumbled more than 11% after the retail pharmacy company reported a third-quarter earnings miss and cut its full-year adjusted profit outlook. Walgreens also said it would close underperforming stores to cut costs. Goldman Sachs — The U.S. banking stock slipped nearly 2% after the latest round of stress test results . The Federal Reserve said that the 31 biggest banks in the U.S. could all withstand a hypothetical severe recession. AeroVironment — Shares tumbled 6% despite the unmanned aerial vehicles manufacturer reporting a fourth-quarter earnings and revenue beat. However, the company reported EBITDA guidance for its fiscal year 2025 that was 5% lower than analyst consensus estimates, according to FactSet. U.S. Bancorp — The bank stock slipped more than 1% following a downgrade to neutral from overweight at J.P. Morgan. Analyst Vivek Juneja said the bank could face pressure due to stiffer capital requirements from stress tests. — CNBC’s Michelle Fox, Alex Harring and Fred Imbert contributed reporting.
EMEA Tribune is not involved in this news article, it is taken from our partners and or from the News Agencies. Copyright and Credit go to the News Agencies, email news@emeatribune.com Follow our WhatsApp verified Channel